Two phases of mitogenic signaling unveil roles for p53 and EGR1 in elimination of inconsistent growth signals.

Normal cells require continuous exposure to growth factors in order to cross a restriction point and commit to cell-cycle progression. This can be replaced by two short, appropriately spaced pulses of growth factors, where the first pulse primes a process, which is completed by the second pulse, and enables restriction point crossing. Through integration of comprehensive proteomic and transcriptomic analyses of each pulse, we identified three processes that regulate restriction point crossing: (1) The first pulse induces essential metabolic enzymes and activates p53-dependent restraining processes. (2) The second pulse eliminates, via the PI3K/AKT pathway, the suppressive action of p53, as well as (3) sets an ERK-EGR1 threshold mechanism, which digitizes graded external signals into an all-or-none decision obligatory for S phase entry. Together, our findings uncover two gating mechanisms, which ensure that cells ignore fortuitous growth factors and undergo proliferation only in response to consistent mitogenic signals.

[1]  Terry M. Therneau,et al.  Faster cyclic loess: normalizing RNA arrays via linear models , 2004, Bioinform..

[2]  V. Band,et al.  Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Pouysségur,et al.  Biphasic and synergistic activation of p44mapk (ERK1) by growth factors: correlation between late phase activation and mitogenicity. , 1992, Molecular endocrinology.

[4]  G. Sa,et al.  P27 expression is regulated by separate signaling pathways, downstream of Ras, in each cell cycle phase. , 2004, Experimental cell research.

[5]  C. Stiles,et al.  Induction of DNA synthesis in BALB/c 3T3 cells by serum components: reevaluation of the commitment process. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Galit Lahav,et al.  Basal Dynamics of p53 Reveal Transcriptionally Attenuated Pulses in Cycling Cells , 2010, Cell.

[7]  J L Cleveland,et al.  Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. , 1998, Genes & development.

[8]  Anne E Carpenter,et al.  CellProfiler: image analysis software for identifying and quantifying cell phenotypes , 2006, Genome Biology.

[9]  Andrius Kazlauskas,et al.  Growth-factor-dependent mitogenesis requires two distinct phases of signalling , 2001, Nature Cell Biology.

[10]  Seiichi Mori,et al.  An E2F1-dependent gene expression program that determines the balance between proliferation and cell death. , 2008, Cancer cell.

[11]  R. Weinberg,et al.  The restriction point and control of cell proliferation. , 1997, Current opinion in cell biology.

[12]  A. Pardee,et al.  A restriction point for control of normal animal cell proliferation. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[13]  K. Struhl,et al.  A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases. , 2010, Cancer cell.

[14]  Eytan Domany,et al.  Intensity dependent estimation of noise in microarrays improves detection of differentially expressed genes , 2010, BMC Bioinformatics.

[15]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[16]  Miki Ebisuya,et al.  Continuous ERK Activation Downregulates Antiproliferative Genes throughout G1 Phase to Allow Cell-Cycle Progression , 2006, Current Biology.

[17]  Andrius Kazlauskas,et al.  PDGF induces an early and a late wave of PI 3-kinase activity, and only the late wave is required for progression through G1 , 1999, Current Biology.

[18]  F. McCormick,et al.  Phosphoinositide 3-OH Kinase (PI3K) and PKB/Akt Delay the Onset of p53-mediated, Transcriptionally Dependent Apoptosis* , 1999, The Journal of Biological Chemistry.

[19]  C. Stiles,et al.  Control of the Balb/c‐3T3 cell cycle by nutrients and serum factors: Analysis using platelet‐derived growth factor and platelet‐poor plasma , 1979, Journal of cellular physiology.

[20]  R. Eckert,et al.  Retinoids Suppress Epidermal Growth Factor-associated Cell Proliferation by Inhibiting Epidermal Growth Factor Receptor-dependent ERK1/2 Activation* , 2002, The Journal of Biological Chemistry.

[21]  M. Vitek,et al.  Akt Activation Protects Hippocampal Neurons from Apoptosis by Inhibiting Transcriptional Activity of p53* , 2001, The Journal of Biological Chemistry.

[22]  Paul S Mischel,et al.  The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis , 2009, Proceedings of the National Academy of Sciences.

[23]  M. Kirschner,et al.  Cell Growth and Size Homeostasis in Proliferating Animal Cells , 2009, Science.

[24]  P. Yaswen,et al.  Blockage of EGF receptor signal transduction causes reversible arrest of normal and immortal human mammary epithelial cells with synchronous reentry into the cell cycle. , 1993, Experimental cell research.

[25]  A. Kazlauskas.  The priming/completion paradigm to explain growth factor-dependent cell cycle progression , 2005, Growth factors.

[26]  M. Kuo,et al.  Distinct p53-mediated G1/S checkpoint responses in two NIH3T3 subclone cells following treatment with DNA-damaging agents. , 1996, Oncogene.

[27]  L. Penn,et al.  Reflecting on 25 years with MYC , 2008, Nature Reviews Cancer.

[28]  A. Pardee.  G1 events and regulation of cell proliferation. , 1989, Science.

[29]  D. Botstein,et al.  The transcriptional program in the response of human fibroblasts to serum. , 1999, Science.

[30]  Tae J. Lee,et al.  A bistable Rb–E2F switch underlies the restriction point , 2008, Nature Cell Biology.

[31]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[32]  A. Rowzee,et al.  Growth Factor Regulation of Cell Cycle Progression in Mammary Epithelial Cells , 2004, Journal of Mammary Gland Biology and Neoplasia.

[33]  Shih-Yin Tsai,et al.  Emerging roles of E2Fs in cancer: an exit from cell cycle control , 2009, Nature Reviews Cancer.

[34]  Eytan Domany,et al.  A module of negative feedback regulators defines growth factor signaling , 2007, Nature Genetics.

[35]  P. Hainaut,et al.  Patterns of EGFR, HER2, TP53, and KRAS mutations of p14arf expression in non-small cell lung cancers in relation to smoking history. , 2007, Cancer research.

[36]  D. Schuppan,et al.  EGFR blockade by cetuximab alone or as combination therapy for growth control of hepatocellular cancer. , 2005, Biochemical pharmacology.

[37]  S. L. Hammond,et al.  Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[38]  H. Beug,et al.  Evidence for a size-sensing mechanism in animal cells , 2004, Nature Cell Biology.

[39]  Amit Kumar,et al.  Phosphoinositide 3-Kinase Activation in Late G1 Is Required for c-Myc Stabilization and S Phase Entry , 2006, Molecular and Cellular Biology.

[40]  J. Nevins,et al.  A role for Myc in facilitating transcription activation by E2F1 , 2008, Oncogene.